Fundraising Fox

Travis Wilson

Investor

Managing Director, CCD at Abingworth

About

Travis Wilson joined Abingworth/Carlyle in November 2025 with over 20 years of life sciences investing and executive experience. At Abingworth he works with the Clinical Co-Development team, and within Carlyle's US Buyout business he focuses on healthcare private equity transactions, particularly in pharma products and services. He previously served as a Growth Partner at Flagship Pioneering, Managing Partner of Gurnet Point Capital, CEO of Stealth BioTherapeutics, and a member of Morningside's venture capital team; he holds Chemical Engineering and Law degrees from the University of Wisconsin.

Invests in

BiotechHealthtech

Investments

Board seats

Boston PharmaceuticalsHarbinger HealthMirai BioValo Health

Investor

ACDAduroApellisBioVexLiquidia

Per the firm's website.

Colleagues at Abingworth

Alex Asquith
Counsel at Abingworth
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Ankur Shah
Vice President, CCD at Abingworth
Anna Slezak
Senior Associate at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Abingworth
Dayle Hogg
Operating Executive at Abingworth
Diya Malhotra
Principal at Abingworth